Processes to better determine a medicine’s value are discussed by Dr. Indranil Bagchi, Vice President, Value and Access, Novartis Oncology, and Dr. Thomas Szucs, Professor of Pharmaceutical Medicine and Director of the European Center of Pharmaceutical Medicine at the University of Basel, who will help lead discussions on value and access at <a href="http://www.diaglobal.org/en/flagship/euromeeting" target="_blank">DIA Europe 2018</a>.

Processes to better determine a medicine’s value are discussed by Dr. Indranil Bagchi, Vice President, Value and Access, Novartis Oncology, and Dr. Thomas Szucs, Professor of Pharmaceutical Medicine and Director of the European Center of Pharmaceutical Medicine at the University of Basel, who will help lead discussions on value and access at DIA Europe 2018.

Processes to better determine a medicine’s value are discussed by Dr. Indranil Bagchi, Vice President, Value and Access, Novartis Oncology, and Dr. Thomas Szucs, Professor of Pharmaceutical Medicine and Director of the European Center of Pharmaceutical Medicine at the University of Basel, who will help lead discussions on value and access at <a href="http://www.diaglobal.org/en/flagship/euromeeting" rel="noopener noreferrer">DIA Europe 2018</a>.

Can Europe Optimize Healthcare Quality AND Pricing?

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

Share Can Europe Optimize Healthcare Quality AND Pricing?

Sign up to save your podcasts

Can Europe Optimize Healthcare Quality AND Pricing?

Can Europe Optimize Healthcare Quality AND Pricing?